Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000217535 | SCV000272016 | uncertain significance | not specified | 2015-10-01 | criteria provided, single submitter | clinical testing | The p.Ala446Thr variant in MYH6 has not been previously reported in individuals with cardiomyopathy, but has been identified in 0.14% (12/8654) of East Asian ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; rs556536964). Computational prediction tools and conservation analysis do n ot provide strong support for or against an impact to the protein. In summary, t he clinical significance of the p.Ala446Thr variant is uncertain. |
Ambry Genetics | RCV000248354 | SCV000319792 | likely benign | Cardiovascular phenotype | 2021-08-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001320565 | SCV001511356 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-12-09 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002494569 | SCV002775251 | uncertain significance | Hypertrophic cardiomyopathy 1; Dilated cardiomyopathy 1EE; Hypertrophic cardiomyopathy 14; Atrial septal defect 3; Sick sinus syndrome 3, susceptibility to | 2022-01-17 | criteria provided, single submitter | clinical testing |